Mineralocorticoid Receptor Antagonists

"Mineralocorticoid Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.

Descriptor ID	D000451
MeSH Number(s)	D06.347.700 D27.505.696.399.450.600 D27.505.696.560.500.726.249
Concept/Terms	Mineralocorticoid Receptor Antagonists Mineralocorticoid Receptor Antagonists Antagonists, Mineralocorticoid Receptor Receptor Antagonists, Mineralocorticoid Mineralocorticoid Antagonists Antagonists, Mineralocorticoid Aldosterone Receptor Antagonists Antagonists, Aldosterone Receptor Receptor Antagonists, Aldosterone Aldosterone Antagonists Aldosterone Antagonists Antagonists, Aldosterone

Below are MeSH descriptors whose meaning is more general than "Mineralocorticoid Receptor Antagonists".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Mineralocorticoid Receptor Antagonists [D06.347.700]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Mineralocorticoid Receptor Antagonists [D27.505.696.399.450.600]
Natriuretic Agents [D27.505.696.560]
Diuretics [D27.505.696.560.500]
Diuretics, Potassium Sparing [D27.505.696.560.500.726]
Mineralocorticoid Receptor Antagonists [D27.505.696.560.500.726.249]

Below are MeSH descriptors whose meaning is related to "Mineralocorticoid Receptor Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Mineralocorticoid Receptor Antagonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mineralocorticoid Receptor Antagonists" by people in this website by year, and whether "Mineralocorticoid Receptor Antagonists" was a major or minor topic of these publications.

Bar chart showing 18 publications over 12 distinct years, with a maximum of 2 publications in 2006 and 2007 and 2008 and 2010 and 2014 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2004	0	1	1
2006	1	1	2
2007	1	1	2
2008	2	0	2
2010	1	1	2
2014	0	2	2
2015	1	0	1
2016	1	0	1
2018	1	1	2
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Mineralocorticoid Receptor Antagonists" by people in Profiles.

Ferreira JP, Collier T, Clark AL, Mamas MA, Rocca HB, Heymans S, Gonz?lez A, Ahmed FZ, Petutschnigg J, Mujaj B, Cuthbert J, Rouet P, Pellicori P, Mariottoni B, Cosmi F, Edelmann F, Thijs L, Staessen JA, Hazebroek M, Verdonschot J, Rossignol P, Girerd N, Cleland JG, Zannad F. Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. Eur Heart J Cardiovasc Pharmacother. 2022 02 16; 8(2):149-156.

View in: PubMed
Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J, D?ez J, Edelmann F, Girerd N, Gonz?lez A, Grojean S, Hazebroek M, Khan J, Latini R, Mamas MA, Mariottoni B, Mujaj B, Pellicori P, Petutschnigg J, Pieske B, Rossignol P, Rouet P, Staessen JA, Cleland JGF, Heymans S, Zannad F. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. JACC Heart Fail. 2021 04; 9(4):268-277.

View in: PubMed
Rahimy E, Pitcher JD, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Retina. 2018 May; 38(5):962-969.

View in: PubMed
Fudim M, Liu PR, Shrader P, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Hylek E, Go AS, Thomas L, Peterson ED, Piccini JP. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. J Am Heart Assoc. 2018 04 13; 7(8).

View in: PubMed
Ghadiali Q, Jung JJ, Yu S, Patel SN, Yannuzzi LA. CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY. Retina. 2016 Mar; 36(3):611-8.

View in: PubMed
Salz DA, Pitcher JD, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr; 46(4):439-44.

View in: PubMed
Subzposh F, Gupta A, Hankins SR, Eisen HJ. Management of ACCF/AHA Stage A and B patients. Cardiol Clin. 2014 Feb; 32(1):63-71, viii.

View in: PubMed
Feitell S, Hankins SR, Eisen HJ. Adjunctive therapy and management of the transition of care in patients with heart failure. Cardiol Clin. 2014 Feb; 32(1):163-74, x.

View in: PubMed
Eckhart AD. Mineralocorticoid receptors, corticosteroids and the heart: where do we stand? J Hypertens. 2010 May; 28(5):889-91.

View in: PubMed
Zhang Z, Mahoney EM, Kolm P, Spertus J, Caro J, Willke R, Weintraub WS. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS. Am J Cardiovasc Drugs. 2010; 10(1):55-63.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement